CD31 is a key coinhibitory receptor in the development of immunogenic dendritic cells

Marc Clement, Giulia Fornasa, Kevin Guedj, Sanae Ben Mkaddem, Anh Thu Gaston, Jamila Khallou-Laschet, Marion Morvan, Antonino Nicoletti, Giuseppina Caligiuri

Research output: Contribution to journalArticlepeer-review


CD31 is a transhomophilic tyrosine-based inhibitory motif receptor and is expressed by both dendritic cells (DCs) and T lymphocytes. Previous studies have established that the engagement of CD31 drives immune-inhibitory signaling in T lymphocytes, but the effect exerted by CD31 signaling in DCs remains elusive. Here, we show that CD31 is a key coinhibitory receptor on stimulated DCs, favoring the development of tolerogenic functions and finally resulting in T-cell tolerance. The disruption of CD31 signaling favored the immunogenic maturation and migration of resident DCs to the draining lymph nodes. In contrast, sustaining the CD31/SHP-1 signaling during DC maturation resulted in reduced NF-κB nuclear translocation, expression of costimulatory molecules, and production of immunogenic cytokines (e.g., IL-12, IL-6), whereas the expression of TGF-β and IL-10 were increased. More importantly, CD31-conditioned DCs purified from the draining lymph nodes of ovalbumin-immunized mice favored the generation of antigen-specific regulatory T cells (CD25+ forkhead box P3+) at the expense of effector (IFN-γ+) cells upon coculture with naive ovalbumin-specific CD4+ T lymphocytes ex vivo. Finally, the adoptive transfer of CD31-conditioned myelin oligodendrocyte glycoprotein-loaded DCs carried immune tolerance against the subsequent development of MOG-induced experimental autoimmune encephalomyelitis in vivo. The key coinhibitory role exerted by CD31 on DCs high-lighted by the present study may have important implications both in settings where the immunogenic function of DCs is desirable, such as infection and cancer, and in settings where tolerance-driving DCs are preferred, such as autoimmune diseases and transplantation.

Original languageEnglish
JournalProceedings of the National Academy of Sciences of the United States of America
Issue number12
Publication statusPublished - Mar 25 2014


  • CD31 tolerance
  • EAE
  • NFkB
  • Treg

ASJC Scopus subject areas

  • General


Dive into the research topics of 'CD31 is a key coinhibitory receptor in the development of immunogenic dendritic cells'. Together they form a unique fingerprint.

Cite this